Use data of all dosed subjects [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2019-09-19 17:16 (2122 d 18:02 ago) – Posting: # 20617
Views: 13,500

Hi Elena,

❝ […] What combined data should be evaluated after stage 2 completion: ONLY for Cmax or for Cmax and AUCt?


Whatever drives the second stage, you have to use all data (Cmax and AUC). Whilst from a statistical perspective there would be no need to assess AUC (already BE in the first stage) no regulator would accept that. Once you dosed subjects, you have to use the data. No way out.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,434 posts in 4,931 threads, 1,676 registered users;
66 visitors (0 registered, 66 guests [including 15 identified bots]).
Forum time: 11:18 CEST (Europe/Vienna)

For every expert there is an equal and opposite expert.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5